Anxiety Disorders - Pipeline Review, H2 2016 - Product Thumbnail Image

Anxiety Disorders - Pipeline Review, H2 2016

  • Report
  • 273 Pages
From
Anxiety Disorders - Pipeline Review, H1 2016 - Product Thumbnail Image

Anxiety Disorders - Pipeline Review, H1 2016

  • Report
  • 284 Pages
From
Anxiety Disorders - Pipeline Review, H2 2015 - Product Thumbnail Image

Anxiety Disorders - Pipeline Review, H2 2015

  • Report
  • 289 Pages
From
Sleep Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Sleep Disorders Drug Development Pipeline Review, 2017

  • Report
  • 76 Pages
From
Schizophrenia: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Schizophrenia: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Schizophrenia Drugs Market Analysis, By Therapeutic Class (Second-Generation, Third-Generation Antipsychotics), By Treatment (Oral, Injectables), By Major Markets, And Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Schizophrenia Drugs Market Analysis, By Therapeutic Class (Second-Generation, Third-Generation Antipsychotics), By Treatment (Oral, Injectables), By Major Markets, And Segment Forecasts, 2016 - 2022

  • Report
  • 103 Pages
From
Schizophrenia - Pipeline Review, H1 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H1 2018

  • Report
  • 334 Pages
From
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2018 - Product Thumbnail Image

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2018

  • Report
  • 87 Pages
From
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2017 - Product Thumbnail Image

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2017

  • Report
  • 104 Pages
From
Schizophrenia - Current and Future Players - Product Thumbnail Image

Schizophrenia - Current and Future Players

  • Report
  • 114 Pages
From
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 - Product Thumbnail Image

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • Report
  • 433 Pages
From
CNS Cluster Addiction Drug Development Pipeline Review, 2017 - Product Thumbnail Image

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Drug Overview: lumateperone - Product Thumbnail Image

Drug Overview: lumateperone

  • Report
  • 25 Pages
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Report
  • 490 Pages
From
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2017 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2017

  • Report
  • 137 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016

  • Report
  • 122 Pages
From
Major Depressive Disorder - Pipeline Review, H2 2016 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Review, H2 2016

  • Report
  • 201 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016

  • Report
  • 126 Pages
From
Major Depressive Disorder - Pipeline Review, H1 2016 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Review, H1 2016

  • Report
  • 224 Pages
From
Post-Traumatic Stress Disorder (PTSD) - Pipeline Insight, 2018 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Loading Indicator
adroll